News | Cardiac Imaging | February 16, 2026

Peer-Reviewed Article Demonstrates Advantages of Hybrid IVUS-OCT Imaging

New academic data supports clinical and commercial value of hybrid imaging platform.

Peer-Reviewed Article Demonstrates Advantages of Hybrid IVUS-OCT Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology,” published in Cardiovascular Research by the European Society of Cardiology.

The study analyzed IVUS-OCT images and matched histological sections from 10 cadaveric human hearts, demonstrating that a histology-trained hybrid IVUS-OCT deep-learning classifier outperformed single-modality IVUS, single-modality OCT, and expert readers in plaque characterization, supporting the clinical and commercial value of a comprehensive hybrid imaging for enhancing treatment planning.

The patented Novasight Hybrid System combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single device, enabling simultaneous and co-registered imaging of coronary arteries.

The publication includes contributions from Dr. Brian Courtney, a pioneer in hybrid IVUS-OCT imaging and co-inventor of the foundational hybrid imaging technology that underpins Conavi’s platform. Co-authors included imaging experts in Canada, Europe and the USA, as well as artificial intelligence researchers at Queen Mary University of London.

“Peer-reviewed academic research continues to reinforce the clinical value proposition behind Conavi’s technology platform,” said Tom Looby, Chief Executive Officer of Conavi Medical. “As the field moves toward more precise, image-guided coronary interventions, research highlighting the complementary strengths of IVUS and OCT underscores the importance of comprehensive hybrid systems.”

Conavi is advancing the development and commercialization of its next-generation hybrid IVUS-OCT imaging solutions and has submitted its next-generation Novasight imaging system to the U.S. Food and Drug Administration (FDA) for regulatory clearance, while continuing preparations to support commercialization and clinical adoption.

For additional details, the publication can be accessed at:
https://academic.oup.com/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvaf281/8443065

Go to www.conavi.com/novasight/ to learn more.


Related Content

News | ESC

Aug. 28, 2025 — A new global systematic literature review and meta-analysis has shown that herpes zoster vaccination ...

Home August 29, 2025
Home
News | ESC

Aug. 28, 2025 — Leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare introduced its ...

Home August 28, 2025
Home
News | ESC

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...

Home April 10, 2024
Home
News | ESC

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...

Home April 10, 2024
Home
News | ESC

August 22, 2023 — Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent ...

Home August 22, 2023
Home
News | ESC

August 22, 2023 — A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood ...

Home August 22, 2023
Home
News | ESC

August 22, 2023 — Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according ...

Home August 22, 2023
Home
News | ESC

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients ...

Home March 23, 2023
Home
News | ESC

March 17, 2023 — Discover what’s new and on the horizon in the prevention and treatment of heart rhythm disorders at ...

Home March 17, 2023
Home
News | ESC

March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...

Home March 11, 2023
Home
Subscribe Now